Improving the Quality of Coronary Artery Bypass Grafting
CABG Quality
Quality Improvement Intervention on Utilization of Arterial Grafts for Coronary Artery Bypass Grafting
2 other identifiers
interventional
8,700
0 countries
N/A
Brief Summary
This is a healthcare quality improvement study focused on increasing the utilization of arterial grafts in isolated coronary artery bypass grafting (CABG). Evidence indicates that arterial grafts, compared with venous grafts, provide superior long-term patency, which are recommended to use by the clinical practice guidelines. In hospitals where the use of the internal mammary artery as a graft is relatively low(\<90%) among CABG patients, multiple interventions will be implemented to improve its adoption rate. In hospitals where internal mammary artery graft utilization is already high(≥90%), various interventions will be introduced to promote the use of multiple arterial grafts (defined as the use of two or more arterial conduits). The study targets healthcare professionals as the primary subjects of intervention, with no direct interventions applied to patients during the study period. Changes in the internal mammary artery graft utilization rate and the multiple arterial graft utilization rate before and after the intervention will serve as the primary endpoints for evaluating intervention effectiveness in the two types of hospitals, respectively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 23, 2025
CompletedFirst Posted
Study publicly available on registry
January 29, 2026
CompletedStudy Start
First participant enrolled
March 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2029
January 29, 2026
January 1, 2026
2.8 years
December 23, 2025
January 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Hospitals with low usage rates of internal mammary artery: internal mammary artery graft utilization rate
Internal mammary artery graft utilization rate: the utilization rate of at least one internal mammary artery graft in patients received isolated coronary artery bypass grafting.
Duration of hospital stay(from date of admission to date of discharge)
Hospitals with high usage rates of internal mammary artery: multiple arterial graft utilization rate
Multiple arterial graft utilization rate: the utilization rate of two or more arterial conduits in patients received isolated coronary artery bypass grafting.
Duration of hospital stay(from date of admission to date of discharge)
Secondary Outcomes (1)
In-hospital all-cause mortality rate
Duration of hospital stay(from date of admission to date of discharge)
Study Arms (1)
Improving the utilization rate of arterial grafts for coronary artery bypass grafting
OTHERIn this stepped-wedge cluster randomized trial (SW-CRT) with a self-controlled design, hospitals were categorized into two groups according to their internal mammary artery graft usage rates, thereby forming two SW-CRT. Healthcare professionals at these hospitals will receive tailored interventions. The effectiveness of each intervention is assessed by comparing the usage rates before and after implementation within each SW-CRT.
Interventions
Hospitals with already high usage rates focus on increasing multi-arterial graft usage rates through similar intervention methods such as education, theoretical training, technical training, conference exchanges focus on multi-arterial graft use. The usage rates of multi-arterial graft for each hospital will be regular feed backed.
Hospitals with low usage rates aim to improve internal mammary artery graft utilization through interventions including education, theoretical training, technical training, conference exchanges, and regular feedback on quality monitoring results.
Eligibility Criteria
You may qualify if:
- Aged ≥ 18 years old; Indicated for CABG and undergoing CABG.
You may not qualify if:
- History of prior CABG; Concurrent other cardiac surgeries on the day of CABG; Malignant tumor or life expectancy \< 1 year;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- China National Center for Cardiovascular Diseaseslead
- Chinese Academy of Medical Sciences, Fuwai Hospitalcollaborator
- Shandong Provincial Hospitalcollaborator
- The First Affiliated Hospital with Nanjing Medical Universitycollaborator
- Guangdong Provincial People's Hospitalcollaborator
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technologycollaborator
- West China Hospitalcollaborator
- First Affiliated Hospital of Wenzhou Medical Universitycollaborator
- Ruijin Hospitalcollaborator
- The General Hospital of Northern Theater Commandcollaborator
- Central China Fuwai Hospital of Zhengzhou Universitycollaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 23, 2025
First Posted
January 29, 2026
Study Start
March 15, 2026
Primary Completion (Estimated)
January 1, 2029
Study Completion (Estimated)
July 1, 2029
Last Updated
January 29, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share